Year |
Citation |
Score |
2013 |
Harvey LE, Kohlgraf KG, Mehalick LA, Raina M, Recker EN, Radhakrishnan S, Prasad SA, Vidva R, Progulske-Fox A, Cavanaugh JE, Vali S, Brogden KA. Defensin DEFB103 bidirectionally regulates chemokine and cytokine responses to a pro-inflammatory stimulus. Scientific Reports. 3: 1232. PMID 23390582 DOI: 10.1038/Srep01232 |
0.334 |
|
2010 |
Kohlgraf KG, Ackermann A, Lu X, Burnell K, Bélanger M, Cavanaugh JE, Xie H, Progulske-Fox A, Brogden KA. Defensins attenuate cytokine responses yet enhance antibody responses to Porphyromonas gingivalis adhesins in mice. Future Microbiology. 5: 115-25. PMID 20020833 DOI: 10.2217/Fmb.09.107 |
0.325 |
|
2010 |
Kohlgraf KG, Pingel LC, Dietrich DE, Brogden KA. Defensins as anti-inflammatory compounds and mucosal adjuvants. Future Microbiology. 5: 99-113. PMID 20020832 DOI: 10.2217/Fmb.09.104 |
0.403 |
|
2008 |
Pingel LC, Kohlgraf KG, Hansen CJ, Eastman CG, Dietrich DE, Burnell KK, Srikantha RN, Xiao X, Bélanger M, Progulske-Fox A, Cavanaugh JE, Guthmiller JM, Johnson GK, Joly S, Kurago ZB, et al. Human beta-defensin 3 binds to hemagglutinin B (rHagB), a non-fimbrial adhesin from Porphyromonas gingivalis, and attenuates a pro-inflammatory cytokine response. Immunology and Cell Biology. 86: 643-9. PMID 18711400 DOI: 10.1038/Icb.2008.56 |
0.323 |
|
2004 |
Kohlgraf KG, Gawron AJ, Higashi M, VanLith ML, Shen X, Caffrey TC, Anderson JM, Hollingsworth MA. Tumor-specific immunity in MUC1.Tg mice induced by immunization with peptide vaccines from the cytoplasmic tail of CD227 (MUC1). Cancer Immunology, Immunotherapy : Cii. 53: 1068-84. PMID 15696607 DOI: 10.1007/S00262-004-0557-1 |
0.703 |
|
2004 |
Turnquist HR, Kohlgraf KG, McIlhaney MM, Mosley RL, Hollingsworth MA, Solheim JC. Tapasin decreases immune responsiveness to a model tumor antigen. Journal of Clinical Immunology. 24: 462-70. PMID 15163903 DOI: 10.1023/B:Joci.0000029118.51587.D9 |
0.764 |
|
2003 |
Kohlgraf KG, Gawron AJ, Higashi M, Meza JL, Burdick MD, Kitajima S, Kelly DL, Caffrey TC, Hollingsworth MA. Contribution of the MUC1 tandem repeat and cytoplasmic tail to invasive and metastatic properties of a pancreatic cancer cell line. Cancer Research. 63: 5011-20. PMID 12941828 |
0.529 |
|
2002 |
VanLith ML, Kohlgraf KG, Sivinski CL, Tempero RM, Hollingsworth MA. MUC1-specific anti-tumor responses: molecular requirements for CD4-mediated responses. International Immunology. 14: 873-82. PMID 12147624 DOI: 10.1093/Intimm/Dxf053 |
0.601 |
|
2002 |
Sivinski CL, Kohlgraf KG, VanLith ML, Morikane K, Tempero RM, Hollingsworth MA. Molecular requirements for CD8-mediated rejection of a MUC1-expressing pancreatic carcinoma: implications for tumor vaccines. Cancer Immunology, Immunotherapy : Cii. 51: 327-40. PMID 12111121 DOI: 10.1007/S00262-002-0277-3 |
0.614 |
|
Show low-probability matches. |